People · Operator
Named in public records as an officer, director or promoter · active 2011–2023 · Pharma, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vibliome Therapeutics, Llc | — | Pharma | Series A | $8.0M | $247.8M | 2019 |
| Flemish Gold Corp. | — | Other | Seed | $3.4M | $62.3M | 2011 |
| CredHub, Inc. | — | Other | Pre-Seed | $525K | $3.7M | 2023 |
ROBERT JACKSON at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside ROBERT JACKSON on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Cameron Wheeler | 1 | 9 |
| MICHAEL FARRELL | 1 | 6 |
| Jean Charles Potvin | 1 | 5 |
| Denis Arsenault | 1 | 5 |
| Bryan Sendrowski | 1 | 3 |
| Claude Britt | 1 | 3 |
| Robert Goodwin | 1 | 3 |
| David Pyper | 1 | 2 |
| Erik Martin | 1 | 2 |
| Jonathan Ramos | 1 | 2 |
| GARY FLYNN | 1 | 2 |
| John Dixon | 1 | 2 |
| Joseph Hasabumutima | 1 | 1 |
| Stephen Jarvis | 1 | 1 |
| CHRISTOPHER DUKELOW | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.